Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 841 AL 855

Antihypertensive drug use and risk of cognitive decline in the very old: an observational study - the Newcastle 85+ Study

Peters R, Collerton J, Granic A, Davies K, Kirkwood T, Jagger C.

J Hypertens. 2015 Oct;33(10):2156-64. doi: 10.1097/HJH.0000000000000653.

Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease

Weintraub D, Drye LT, Porsteinsson AP, Rosenberg PB, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Yesavage J, Lyketsos CG; CitAD Research Group.

Am J Geriatr Psychiatry. 2015 Nov;23(11):1127-33. doi: 10.1016/j.jagp.2015.05.006. Epub 2015 May 19.

A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

Wiseman FK, Al-Janabi T, Hardy J, Karmiloff-Smith A, Nizetic D, Tybulewicz VL, Fisher EM, Strydom A.

Nat Rev Neurosci. 2015 Sep;16(9):564-74. doi: 10.1038/nrn3983. Epub 2015 Aug 5.

Elevated galanin may predict the risk of type 2 diabetes mellitus for development of Alzheimer's disease

Zhang Z, Fang P, Shi M, Zhu Y, Bo P.

Mech Ageing Dev. 2015 Sep;150:20-6. doi: 10.1016/j.mad.2015.08.001. Epub 2015 Aug 4.

Mini-Mental State Examination for the Detection of Alzheimer Disease and Other Dementias in People With Mild Cognitive Impairment

Skorga P, Young CF.

Clin Nurse Spec. 2015 Sep-Oct;29(5):265-7. doi: 10.1097/NUR.0000000000000150.

EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW

de Souza Fernandes DP, Canaan Rezende FA, Pereira Rocha G, De Santis Filgueiras M, Silva Moreira PR, Gonçalves Alfenas Rde C.

Nutr Hosp. 2015 Aug 1;32(2):528-33. doi: 10.3305/nh.2015.32.2.9111.

Effect of an interactive therapeutic robotic animal on engagement, mood states, agitation and psychotropic drug use in people with dementia: a cluster-randomised controlled trial protocol

Moyle W, Beattie E, Draper B, Shum D, Thalib L, Jones C, O'Dwyer S, Mervin C.

BMJ Open. 2015 Aug 12;5(8):e009097. doi: 10.1136/bmjopen-2015-009097.

Intellectual and physical activities, but not social activities, are associated with better global cognition: a multi-site evaluation of the cognition and lifestyle activity study for seniors in Asia (CLASSA)

Lam LC, Ong PA, Dikot Y, Sofiatin Y, Wang H, Zhao M, Li W, Dominguez J, Natividad B, Yusoff S, Fu JL, Senanarong V, Fung AW, Lai K.

Age Ageing. 2015 Sep;44(5):835-40. doi: 10.1093/ageing/afv099. Epub 2015 Aug 12.

Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease

Liu CS, Chau SA, Ruthirakuhan M, Lanctôt KL, Herrmann N.

CNS Drugs. 2015 Aug;29(8):615-23. doi: 10.1007/s40263-015-0270-y.

Prescription Opioids and Risk of Dementia or Cognitive Decline: A Prospective Cohort Study

Dublin S, Walker RL, Gray SL, Hubbard RA, Anderson ML, Yu O, Crane PK, Larson EB.

J Am Geriatr Soc. 2015 Aug;63(8):1519-26. doi: 10.1111/jgs.13562.

Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer's dementia

Huang CW, Tsai MH, Chen NC, Chen WH, Lu YT, Lui CC, Chang YT, Chang WN, Chang AY, Chang CC.

Thromb Haemost. 2015 Nov 25;114(6):1230-40. doi: 10.1160/TH14-11-0938. Epub 2015 Aug 20.

Meta-analysis of modifiable risk factors for Alzheimer's disease

Xu W, Tan L, Wang HF, Jiang T, Tan MS, Tan L, Zhao QF, Li JQ, Wang J, Yu JT.

J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1299-306. doi: 10.1136/jnnp-2015-310548. Epub 2015 Aug 20.

An evaluation of Snoezelen(®) compared to 'common best practice' for allaying the symptoms of wandering and restlessness among residents with dementia in aged care facilities

Bauer M, Rayner JA, Tang J, Koch S, While C, O'Keefe F.

Geriatr Nurs. 2015 Nov-Dec;36(6):462-6. doi: 10.1016/j.gerinurse.2015.07.005. Epub 2015 Aug 17.

Lifestyles and Cognitive Health: What Older Individuals Can Do to Optimize Cognitive Outcomes

Gill SS, Seitz DP.

JAMA. 2015 Aug 25;314(8):774-5. doi: 10.1001/jama.2015.9526.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias